Cipla strikes deal in Algeria; Fresenius sells compounding biz; FDA issues compounding draft guidance;

> The FDA has issued 5 new draft guidance documents on compounding and packaging drugs. Release

> Cipla has struck yet another international deal, this one in Algeria. Story

> Fresenius Kabi has sold its German drug compounding business CFL to NewCo Pharma for an undisclosed amount. Report

Suggested Articles

Recipharm has been building its capabilities in sterile injectable and inhalation drugs. Now it is buying a CDMO that manufactures devices for both.

The FDA has slapped the parent of Dollar Tree stores with a warning letter saying some CMOs that made its OTC products were among the world's worst.

GSK expects Shingrix supplies to rise slightly in 2020, but the real "step change" will come in 2024 with a brand-new manufacturing facility.